|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EPHA4-COL4A3 (FusionGDB2 ID:HG2043TG1285) |
Fusion Gene Summary for EPHA4-COL4A3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EPHA4-COL4A3 | Fusion gene ID: hg2043tg1285 | Hgene | Tgene | Gene symbol | EPHA4 | COL4A3 | Gene ID | 2043 | 1285 |
Gene name | EPH receptor A4 | collagen type IV alpha 3 chain | |
Synonyms | EK8|HEK8|SEK|TYRO1 | ATS2|ATS3 | |
Cytomap | ('EPHA4')('COL4A3') 2q36.1 | 2q36.3 | |
Type of gene | protein-coding | protein-coding | |
Description | ephrin type-A receptor 4EPH-like kinase 8TYRO1 protein tyrosine kinasereceptor protein-tyrosine kinase HEK8tyrosine-protein kinase TYRO1tyrosine-protein kinase receptor SEK | collagen alpha-3(IV) chaincollagen IV, alpha-3 polypeptidecollagen, type IV, alpha 3 (Goodpasture antigen)tumstatin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000281821, ENST00000392071, ENST00000409854, ENST00000409938, ENST00000469354, | ||
Fusion gene scores | * DoF score | 4 X 3 X 3=36 | 3 X 4 X 2=24 |
# samples | 4 | 4 | |
** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: EPHA4 [Title/Abstract] AND COL4A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EPHA4(222428451)-COL4A3(228102684), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EPHA4 | GO:0018108 | peptidyl-tyrosine phosphorylation | 12775584 |
Hgene | EPHA4 | GO:0046777 | protein autophosphorylation | 12775584 |
Hgene | EPHA4 | GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 12775584 |
Tgene | COL4A3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 10766752 |
Tgene | COL4A3 | GO:0016525 | negative regulation of angiogenesis | 10766752|12682293 |
Tgene | COL4A3 | GO:0072577 | endothelial cell apoptotic process | 10766752 |
Tgene | COL4A3 | GO:1905563 | negative regulation of vascular endothelial cell proliferation | 10766752 |
Fusion gene breakpoints across EPHA4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across COL4A3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-34-5236-01A | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
Top |
Fusion Gene ORF analysis for EPHA4-COL4A3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000281821 | ENST00000468753 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
5CDS-intron | ENST00000392071 | ENST00000468753 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
5CDS-intron | ENST00000409854 | ENST00000468753 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
5CDS-intron | ENST00000409938 | ENST00000468753 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
Frame-shift | ENST00000392071 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
Frame-shift | ENST00000409938 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
In-frame | ENST00000281821 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
In-frame | ENST00000409854 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
intron-3CDS | ENST00000469354 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
intron-intron | ENST00000469354 | ENST00000468753 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000281821 | EPHA4 | chr2 | 222428451 | - | ENST00000396578 | COL4A3 | chr2 | 228102684 | + | 8713 | 865 | 601 | 5790 | 1729 |
ENST00000409854 | EPHA4 | chr2 | 222428451 | - | ENST00000396578 | COL4A3 | chr2 | 228102684 | + | 8706 | 858 | 594 | 5783 | 1729 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000281821 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + | 0.001288369 | 0.9987116 |
ENST00000409854 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + | 0.001275697 | 0.9987243 |
Top |
Fusion Genomic Features for EPHA4-COL4A3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
EPHA4 | chr2 | 222428450 | - | COL4A3 | chr2 | 228102683 | + | 7.43E-05 | 0.9999256 |
EPHA4 | chr2 | 222428450 | - | COL4A3 | chr2 | 228102683 | + | 7.43E-05 | 0.9999256 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EPHA4-COL4A3 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:222428451/chr2:228102684) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 30_209 | 274 | 2072.6666666666665 | Domain | Eph LBD |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 30_209 | 274 | 987.0 | Domain | Eph LBD |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1445_1669 | 29 | 1671.0 | Domain | Collagen IV NC1 | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1154_1156 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1306_1308 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1345_1347 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1432_1434 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 791_793 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 996_998 | 29 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1427_1444 | 29 | 1671.0 | Region | Note=Epitope recognized by Goodpasture antibodies | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1479_1557 | 29 | 1671.0 | Region | Note=Required for the anti-angiogenic activity of tumstatin | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1610_1628 | 29 | 1671.0 | Region | Note=Required for the anti-tumor cell activity of tumstatin | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 29_42 | 29 | 1671.0 | Region | Note=7S domain | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 43_1438 | 29 | 1671.0 | Region | Note=Triple-helical region |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 191_325 | 274 | 2072.6666666666665 | Compositional bias | Note=Cys-rich |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 191_325 | 274 | 987.0 | Compositional bias | Note=Cys-rich |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 328_439 | 274 | 2072.6666666666665 | Domain | Fibronectin type-III 1 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 440_537 | 274 | 2072.6666666666665 | Domain | Fibronectin type-III 2 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 621_882 | 274 | 2072.6666666666665 | Domain | Protein kinase |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 911_975 | 274 | 2072.6666666666665 | Domain | SAM |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 328_439 | 274 | 987.0 | Domain | Fibronectin type-III 1 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 440_537 | 274 | 987.0 | Domain | Fibronectin type-III 2 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 621_882 | 274 | 987.0 | Domain | Protein kinase |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 911_975 | 274 | 987.0 | Domain | SAM |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 984_986 | 274 | 2072.6666666666665 | Motif | PDZ-binding |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 984_986 | 274 | 987.0 | Motif | PDZ-binding |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 627_635 | 274 | 2072.6666666666665 | Nucleotide binding | ATP |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 627_635 | 274 | 987.0 | Nucleotide binding | ATP |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 20_547 | 274 | 2072.6666666666665 | Topological domain | Extracellular |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 570_986 | 274 | 2072.6666666666665 | Topological domain | Cytoplasmic |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 20_547 | 274 | 987.0 | Topological domain | Extracellular |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 570_986 | 274 | 987.0 | Topological domain | Cytoplasmic |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 548_569 | 274 | 2072.6666666666665 | Transmembrane | Helical |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 548_569 | 274 | 987.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for EPHA4-COL4A3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>26960_26960_1_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000281821_COL4A3_chr2_228102684_ENST00000396578_length(transcript)=8713nt_BP=865nt CTGGGATAGAAGCGGCAGGAGCAGCGTTGGCACCGGCGAACCATGGCTGGGATTTTCTATTTCGCCCTATTTTCGTGTCTCTTCGGGATT TGCGACGCTGTCACAGGTTCCAGGGTATACCCCGCGAATGAAGTTACCTTATTGGATTCCAGATCTGTTCAGGGAGAACTTGGGTGGATA GCAAGCCCTCTGGAAGGAGGGTGGGAGGAAGTGAGTATCATGGATGAAAAAAATACACCAATCCGAACCTACCAAGTGTGCAATGTGATG GAACCCAGCCAGAATAACTGGCTACGAACTGATTGGATCACCCGAGAAGGGGCTCAGAGGGTGTATATTGAGATTAAATTCACCTTGAGG GACTGCAATAGTCTTCCGGGCGTCATGGGGACTTGCAAGGAGACGTTTAACCTGTACTACTATGAATCAGACAACGACAAAGAGCGTTTC ATCAGAGAGAACCAGTTTGTCAAAATTGACACCATTGCTGCTGATGAGAGCTTCACCCAAGTGGACATTGGTGACAGAATCATGAAGCTG AACACCGAGATCCGGGATGTAGGGCCATTAAGCAAAAAGGGGTTTTACCTGGCTTTTCAGGATGTGGGGGCCTGCATCGCCCTGGTATCA GTCCGTGTGTTCTATAAAAAGTGTCCACTCACAGTCCGCAATCTGGCCCAGTTTCCTGACACCATCACAGGGGCTGATACGTCTTCCCTG GTGGAAGTTCGAGGCTCCTGTGTCAACAACTCAGAAGAGAAAGATGTGCCAAAAATGTACTGTGGGGCAGATGGTGAATGGCTGGTACCC ATTGGCAACTGCCTATGCAACGCTGGGCATGAGGAGCGGAGCGGAGAATGCCAAGGGTTGTGTCTGTAAAGACAAAGGCCAGTGCTTCTG TGACGGGGCCAAAGGGGAGAAGGGGGAGAAGGGCTTTCCTGGACCCCCCGGTTCTCCTGGCCAGAAAGGATTCACAGGTCCTGAAGGCTT GCCTGGACCGCAGGGACCCAAGGGCTTTCCAGGACTTCCAGGACTCACGGGTTCCAAAGGTGTAAGGGGAATAAGTGGATTGCCAGGATT TTCTGGTTCTCCTGGACTTCCAGGCACCCCAGGCAATACCGGGCCTTACGGACTTGTCGGTGTACCAGGATGCAGTGGTTCTAAGGGTGA GCAGGGGTTTCCAGGACTCCCAGGGACACTGGGCTACCCAGGGATCCCGGGTGCTGCTGGTTTGAAAGGACAAAAGGGTGCTCCTGCTAA AGAAGAAGATATAGAACTTGATGCAAAAGGCGACCCCGGGTTGCCAGGGGCTCCAGGACCCCAGGGTTTGCCAGGCCCTCCAGGTTTTCC TGGGCCTGTTGGCCCACCTGGTCCTCCGGGATTCTTTGGCTTTCCAGGAGCCATGGGACCTAGAGGACCTAAGGGTCACATGGGTGAAAG AGTGATAGGACATAAAGGAGAGCGGGGTGTGAAAGGGTTAACAGGACCCCCGGGACCACCAGGAACAGTTATTGTGACCCTAACTGGCCC AGATAACAGAACGGACCTCAAGGGGGAAAAGGGAGACAAGGGAGCAATGGGCGAGCCTGGACCTCCTGGACCCTCAGGACTGCCTGGAGA ATCATATGGATCTGAAAAGGGTGCTCCTGGAGACCCTGGCCTGCAGGGAAAACCCGGAAAAGATGGTGTTCCTGGCTTCCCTGGAAGTGA GGGAGTCAAGGGCAACAGGGGTTTCCCTGGGTTAATGGGTGAAGATGGCATTAAGGGACAGAAAGGGGACATTGGCCCTCCAGGATTTCG TGGTCCAACAGAATATTATGACACATACCAGGAAAAGGGAGATGAAGGCACTCCAGGCCCACCAGGGCCCAGAGGAGCTCGTGGCCCACA AGGTCCCAGTGGTCCCCCCGGAGTTCCTGGAAGTCCTGGATCATCAAGGCCTGGCCTCAGAGGAGCCCCTGGATGGCCAGGCCTGAAAGG AAGTAAAGGGGAACGAGGCCGCCCAGGAAAGGATGCCATGGGGACTCCTGGGTCCCCAGGTTGTGCTGGTTCACCAGGTCTTCCAGGATC ACCGGGACCTCCAGGACCGCCAGGTGACATCGTTTTTCGCAAGGGTCCACCTGGAGATCACGGACTGCCAGGCTATCTAGGGTCTCCAGG AATCCCAGGAGTTGATGGGCCCAAAGGAGAACCAGGCCTCCTGTGTACACAGTGCCCTTATATCCCAGGGCCTCCCGGTCTCCCAGGATT GCCAGGGTTACATGGTGTAAAAGGAATCCCAGGAAGACAAGGCGCAGCTGGCTTGAAAGGAAGCCCAGGGTCCCCAGGAAATACAGGTCT TCCAGGATTTCCAGGTTTCCCAGGTGCCCAGGGTGACCCAGGACTTAAAGGAGAAAAAGGTGAAACACTTCAGCCTGAGGGGCAAGTGGG TGTCCCAGGTGACCCGGGGCTCAGAGGCCAACCTGGGAGAAAGGGCTTGGATGGAATTCCTGGAACTCCGGGAGTGAAAGGATTACCAGG ACCTAAAGGCGAACTGGCTCTGAGTGGTGAGAAAGGGGACCAAGGTCCTCCAGGGGATCCTGGCTCCCCTGGGTCCCCAGGACCTGCAGG ACCAGCTGGACCACCTGGCTACGGACCCCAAGGAGAACCTGGTCTCCAGGGCACGCAAGGAGTTCCTGGAGCCCCCGGACCACCCGGAGA AGCCGGCCCTAGGGGAGAGCTCAGTGTTTCAACACCAGTTCCAGGCCCACCAGGACCTCCAGGGCCCCCTGGCCATCCTGGCCCCCAAGG TCCACCTGGTATCCCTGGATCCCTGGGGAAATGTGGAGATCCTGGTCTTCCAGGGCCTGATGGTGAACCAGGAATTCCAGGAATTGGATT TCCTGGGCCTCCTGGACCTAAGGGAGACCAAGGTTTTCCAGGTACAAAAGGATCACTGGGTTGTCCTGGAAAAATGGGAGAGCCTGGGTT ACCTGGAAAGCCAGGCCTCCCAGGAGCCAAGGGAGAACCAGCAGTAGCCATGCCTGGAGGACCAGGAACACCAGGTTTTCCAGGAGAAAG AGGCAATTCTGGGGAACATGGAGAAATTGGACTCCCTGGACTTCCAGGTCTCCCTGGAACTCCAGGAAATGAAGGGCTTGATGGACCACG AGGAGATCCAGGGCAGCCTGGACCACCTGGAGAACAAGGACCCCCAGGAAGGTGCATAGAGGGTCCCAGGGGAGCCCAAGGACTTCCAGG CTTAAATGGATTGAAAGGGCAACAAGGCAGAAGAGGTAAAACGGGGCCAAAGGGAGACCCAGGAATTCCAGGCTTGGATAGATCAGGATT TCCTGGAGAAACTGGATCACCAGGAATTCCAGGTCATCAAGGTGAAATGGGACCACTGGGTCAAAGAGGATATCCAGGAAATCCGGGAAT TTTAGGGCCACCAGGTGAAGATGGAGTGATTGGGATGATGGGCTTTCCTGGAGCCATTGGCCCTCCAGGGCCCCCTGGGAACCCAGGCAC ACCAGGGCAGAGGGGGAGCCCTGGAATTCCAGGAGTAAAGGGCCAGAGAGGAACCCCAGGAGCCAAGGGGGAACAAGGAGATAAAGGAAA TCCCGGGCCTTCAGAGATATCCCACGTAATAGGGGACAAAGGAGAACCAGGTCTCAAAGGATTCGCAGGAAATCCAGGTGAGAAAGGAAA CAGAGGCGTTCCAGGGATGCCAGGTTTAAAGGGCCTCAAAGGACTACCCGGACCAGCAGGACCACCAGGCCCCAGAGGAGATTTGGGCAG CACTGGGAATCCTGGAGAACCAGGACTGCGTGGTATACCAGGAAGCATGGGGAACATGGGCATGCCAGGTTCTAAAGGAAAAAGGGGAAC TTTGGGATTCCCAGGTCGAGCAGGAAGACCAGGCCTCCCAGGTATTCATGGTCTCCAGGGAGATAAGGGAGAGCCAGGTTATTCAGAAGG TACAAGGCCAGGACCACCGGGACCAACGGGGGATCCAGGACTGCCGGGTGATATGGGAAAGAAAGGAGAAATGGGGCAACCTGGCCCACC TGGACATTTGGGGCCTGCTGGACCTGAGGGAGCCCCTGGAAGTCCTGGAAGTCCTGGCCTCCCAGGAAAGCCAGGTCCTCATGGTGATTT GGGTTTTAAAGGAATCAAAGGCCTCCTGGGCCCTCCAGGAATCAGAGGCCCTCCAGGTCTTCCAGGATTTCCAGGATCTCCTGGACCAAT GGGTATAAGAGGTGACCAAGGACGTGATGGAATTCCTGGTCCAGCCGGAGAAAAGGGAGAAACGGGTTTATTGAGGGCCCCTCCAGGCCC AAGAGGGAACCCTGGTGCTCAAGGAGCCAAAGGAGACAGGGGAGCCCCAGGTTTTCCTGGCCTCCCGGGCAGAAAAGGGGCCATGGGAGA TGCTGGACCTCGAGGACCCACAGGCATAGAAGGATTCCCAGGGCCACCAGGTCTGCCCGGTGCAATTATCCCTGGCCAGACAGGAAATCG TGGTCCACCAGGCTCAAGAGGAAGCCCAGGTGCGCCTGGTCCCCCTGGACCTCCAGGGAGTCATGTAATAGGCATAAAAGGAGACAAAGG GTCTATGGGCCACCCTGGCCCAAAAGGTCCACCTGGAACTGCAGGAGACATGGGACCACCAGGTCGTCTGGGAGCACCAGGTACTCCAGG TCTTCCAGGACCCAGAGGTGATCCTGGATTCCAGGGGTTTCCAGGCGTGAAAGGAGAAAAGGGTAATCCTGGATTTCTAGGATCCATTGG ACCTCCAGGACCAATTGGGCCAAAAGGACCACCTGGTGTACGTGGAGACCCTGGCACACTTAAGATTATCTCCCTTCCAGGAAGCCCAGG GCCACCTGGCACACCTGGAGAACCAGGGATGCAGGGAGAACCTGGGCCACCAGGGCCACCTGGAAACCTAGGACCCTGTGGGCCAAGAGG TAAGCCAGGCAAGGATGGAAAACCAGGAACTCCTGGACCAGCTGGAGAAAAAGGCAACAAAGGTTCTAAAGGAGAGCCAGGACCAGCTGG ATCAGATGGATTGCCAGGTTTGAAAGGAAAACGTGGAGACAGTGGATCACCTGCAACCTGGACAACGAGAGGCTTTGTCTTCACCCGACA CAGTCAAACCACAGCAATTCCTTCATGTCCAGAGGGGACAGTGCCACTCTACAGTGGGTTTTCTTTTCTTTTTGTACAAGGAAATCAACG AGCCCACGGACAAGACCTTGGAACTCTTGGCAGCTGCCTGCAGCGATTTACCACAATGCCATTCTTATTCTGCAATGTCAATGATGTATG TAATTTTGCATCTCGAAATGATTATTCATACTGGCTGTCAACACCAGCTCTGATGCCAATGAACATGGCTCCCATTACTGGCAGAGCCCT TGAGCCTTATATAAGCAGATGCACTGTTTGTGAAGGTCCTGCGATCGCCATAGCCGTTCACAGCCAAACCACTGACATTCCTCCATGTCC TCACGGCTGGATTTCTCTCTGGAAAGGATTTTCATTCATCATGTTCACAAGTGCAGGTTCTGAGGGCACCGGGCAAGCACTGGCCTCCCC TGGCTCCTGCCTGGAAGAATTCCGAGCCAGCCCATTTCTAGAATGTCATGGAAGAGGAACGTGCAACTACTATTCAAATTCCTACAGTTT CTGGCTGGCTTCATTAAACCCAGAAAGAATGTTCAGAAAGCCTATTCCATCAACTGTGAAAGCTGGGGAATTAGAAAAAATAATAAGTCG CTGTCAGGTGTGCATGAAGAAAAGACACTGAAGCTAAAAAAGACAGCAGAACTGCTATTTTTCATCCTAAAGAACAAAGTAATGACAGAA CATGCTGTTATTTAGGTATTTTTCTTTAACCAAACAATATTGCTCCATGATGACTTAGTACAAAGTTTCAATTTGTTTCCCCACAAAACA AAGCAATTCTTTCAAGTCAGTTCTGTGATCTGGGTCTCTAATCTGTGCTGTTTCAAAGTTCTCTGTGGCAAAGCAGCAACTATTCACAAA ATATCACCAAAAACCTATTCCACTTACATCCAAGGCACTGTCACTACGGTGATTGTATGAAGTTTGAATGCTGCAAGTTATGAAATATTT GGCCCGCTGGATTCCCACATTTGTCTTCTTTCTGTCTTTAAGACTCAGGGAGGCTAAATCAGTGTTTGATTGCCCCGCCAACCCTTCCTG AAACTTCAGACCCTGGGTAGGGGAAGAGAAGGGGGCATGTGGTATCCTGGAGCATTGTGTATAGAACTGGATTTTCAGACCTGCTGAGGA CCGTAAGGCCTGATGGAACACAGAACTGAACTGAGGTTCATGGATTTTCCAGGACTGTTTCAAACATGCCCATTACTAACGGCAAAAGGG GGATTCCCTGATGGAACCATAATACCCTTGGAAATACTGTATGGTTTTGTTTTGTTTTGTTGGTTTTTAAAGATTTTTGTTTGTTTATTG AATTCATTTCACTGTAGCTCTAAAATCTGCTTGTATTCCAAGCATATAAAATTTTCCCCCTTAGTGAATTAGTTTTAAAATGATATTGTT ATATACATACTATGAAATATGTATAACTTTAACTTCTGTTTTACCAGCATACCCACACAAATAACAAGAATACTACTTATGAAATGTGCA CTTTATCCTCATTCCATAAATGTCGGTGCATACCTTATGTAAGGGAGCAGTTCAATAATCCATGAAAGAACTTAAGGCATTTGTTGGTTT ATCAGACTCGGAATCTATTTTCTCATTGCTCTGAATATGTCATCACTCTAGGTTTTACAGATTTATTCCTTTGTTACTTCTCTAATTCTT CCTTTGTAAAAAAAAAAAAAAGCAACACTTTTTATGTTATATGTTGTTCTTACAAACCATACTGAAAGAGTCCATTGTTTAAAAATCTTA ATGTATCAAACTGTATAACTTGGCCGCTGTATGTCTTAAAACCTGCTTTTCAATGTGTTGATACATTCCCAAGGTTACTTAATTCAACTT AACTATCATCTTATTCAGCACCAAGCATGTCCCAGGCACTGTACTAACCTACAGAGATGCTAAGAGAAAAAAAAGACTTGTTTCTGATCT AATATCCCAGAAAAAGTAACTCATTGCTCTGTTAATAATCTCACATATACAAGTAGCTTCCCTCCCCTCTAGTTTTTTCTTCCTTTTCAC TGCTGTTATATTTCATCATGATAATTCAGCAGGCCCAAGTAAAGGTTAAAAATAAGGTCTATGCCTAGGGAAACTCAGGGCTTCTAGTTT CTCTTAGAAAAGCTAAGAGAAGATAAGGTCTGAATAATAGCAGAAAAACCAACATCTACAAAACATTAAACTAGTGTTATACTTGATGAT AACACTATTTGATGAGTCTTAGAGTCCAGACACAAAGAGACAAAGCTTTGAAGATGCTTTTTGATCTACCTAGGTGGAGTTGGTGGTGCT GATATTTAAATTCAGGCTACTGCTTCAATCTCAATTGCTTTGTAAGTGAAAAACATGACCCAGAGGACAGCACAGACTATGGCCATGGCT CACATGGTTTACATCCTTCACTGCTCACGTGTTTGCTGTCAAGCCATTTTTACATCTAAACTAAGATGTGCAGCATTTCACTTATTTAGA TTCACTTAACAAACAAATTTTTCTGCTTTAAAAATGTCTTATTGTCCCAAGTGTACTATAGCGGCATATAGAGCTAGCTAATCTCTACAA ACCCTCTGTAGGCCAGTAGTTCTCAAAGTGTGGTCTCTGGAAGAGCAGTATCAGCATCATCTGGGAACTTGTCACAGATGCAGATTCTAG GGACCACTCCAGACCTACACAATCAGAAACTCTTGGGGGAGGGCCCGAAATATCTATGTTTTACCAAGCCCACCACATGATTCTGATGTA CTCTAAATACTGAGAAAACCTGTTCTAGACAAATACCCAAGCAACAACTCCGCAGGCAGTTACCAAGTACGGCTGGCTACAACTGCTCCA TCCGTGCCTCTTTTTAAAGTTCAAACTCACAGGTGACTCTAAGGTTATCTACTTTTACTCATAAGTAAAAGCCCTAGACTGGTGCTAATG TCAAACCACTGGCCTCCACTCAGGCCTCCATCTTCTCATGCCCTCTTACCAGTATTTAACTTCTGAGGAAGACAAGTGATGCTAAAACCT GAAATTCCAATGAAGCCATATGAACAGCTGTTCAGTTGCACTTCTAAGACTTTACTTAGCAGTAAATTATAGCTCATGTGCATTATTTTC CAGATAACTTAGCTTATGAGTAGCTTATACAATTATGAAGATTTAATATTACAGATAAAATGTAAACTGTTTCTTTAAAATTGGGGCTTC AACTTTGGAATTTCACAGCGTGCTAAAATAACAGATTTCTCAGAAGTCTTTCAGCAAGATAAACATTATTAAGTAACTTATTTATGAAAG TATTAAAATGCTTACATTTGAACTTGATGGCTAACTTACAAAGATTCTCTATGTATCAAATGTAACTTACTGCGACTAAACTTAATTTAA TATTTACTCTATAACCAAATGAAATATATTTAAAATATATTGAATATTTTATATTGTTATATCCTGACAAGATTATAATATTTTAATGTA >26960_26960_1_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000281821_COL4A3_chr2_228102684_ENST00000396578_length(amino acids)=1729AA_BP=1161 MWGPASPWYQSVCSIKSVHSQSAIWPSFLTPSQGLIRLPWWKFEAPVSTTQKRKMCQKCTVGQMVNGWYPLATAYATLGMRSGAENAKGC VCKDKGQCFCDGAKGEKGEKGFPGPPGSPGQKGFTGPEGLPGPQGPKGFPGLPGLTGSKGVRGISGLPGFSGSPGLPGTPGNTGPYGLVG VPGCSGSKGEQGFPGLPGTLGYPGIPGAAGLKGQKGAPAKEEDIELDAKGDPGLPGAPGPQGLPGPPGFPGPVGPPGPPGFFGFPGAMGP RGPKGHMGERVIGHKGERGVKGLTGPPGPPGTVIVTLTGPDNRTDLKGEKGDKGAMGEPGPPGPSGLPGESYGSEKGAPGDPGLQGKPGK DGVPGFPGSEGVKGNRGFPGLMGEDGIKGQKGDIGPPGFRGPTEYYDTYQEKGDEGTPGPPGPRGARGPQGPSGPPGVPGSPGSSRPGLR GAPGWPGLKGSKGERGRPGKDAMGTPGSPGCAGSPGLPGSPGPPGPPGDIVFRKGPPGDHGLPGYLGSPGIPGVDGPKGEPGLLCTQCPY IPGPPGLPGLPGLHGVKGIPGRQGAAGLKGSPGSPGNTGLPGFPGFPGAQGDPGLKGEKGETLQPEGQVGVPGDPGLRGQPGRKGLDGIP GTPGVKGLPGPKGELALSGEKGDQGPPGDPGSPGSPGPAGPAGPPGYGPQGEPGLQGTQGVPGAPGPPGEAGPRGELSVSTPVPGPPGPP GPPGHPGPQGPPGIPGSLGKCGDPGLPGPDGEPGIPGIGFPGPPGPKGDQGFPGTKGSLGCPGKMGEPGLPGKPGLPGAKGEPAVAMPGG PGTPGFPGERGNSGEHGEIGLPGLPGLPGTPGNEGLDGPRGDPGQPGPPGEQGPPGRCIEGPRGAQGLPGLNGLKGQQGRRGKTGPKGDP GIPGLDRSGFPGETGSPGIPGHQGEMGPLGQRGYPGNPGILGPPGEDGVIGMMGFPGAIGPPGPPGNPGTPGQRGSPGIPGVKGQRGTPG AKGEQGDKGNPGPSEISHVIGDKGEPGLKGFAGNPGEKGNRGVPGMPGLKGLKGLPGPAGPPGPRGDLGSTGNPGEPGLRGIPGSMGNMG MPGSKGKRGTLGFPGRAGRPGLPGIHGLQGDKGEPGYSEGTRPGPPGPTGDPGLPGDMGKKGEMGQPGPPGHLGPAGPEGAPGSPGSPGL PGKPGPHGDLGFKGIKGLLGPPGIRGPPGLPGFPGSPGPMGIRGDQGRDGIPGPAGEKGETGLLRAPPGPRGNPGAQGAKGDRGAPGFPG LPGRKGAMGDAGPRGPTGIEGFPGPPGLPGAIIPGQTGNRGPPGSRGSPGAPGPPGPPGSHVIGIKGDKGSMGHPGPKGPPGTAGDMGPP GRLGAPGTPGLPGPRGDPGFQGFPGVKGEKGNPGFLGSIGPPGPIGPKGPPGVRGDPGTLKIISLPGSPGPPGTPGEPGMQGEPGPPGPP GNLGPCGPRGKPGKDGKPGTPGPAGEKGNKGSKGEPGPAGSDGLPGLKGKRGDSGSPATWTTRGFVFTRHSQTTAIPSCPEGTVPLYSGF SFLFVQGNQRAHGQDLGTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVH SQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVK -------------------------------------------------------------- >26960_26960_2_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000409854_COL4A3_chr2_228102684_ENST00000396578_length(transcript)=8706nt_BP=858nt AGAAGCGGCAGGAGCAGCGTTGGCACCGGCGAACCATGGCTGGGATTTTCTATTTCGCCCTATTTTCGTGTCTCTTCGGGATTTGCGACG CTGTCACAGGTTCCAGGGTATACCCCGCGAATGAAGTTACCTTATTGGATTCCAGATCTGTTCAGGGAGAACTTGGGTGGATAGCAAGCC CTCTGGAAGGAGGGTGGGAGGAAGTGAGTATCATGGATGAAAAAAATACACCAATCCGAACCTACCAAGTGTGCAATGTGATGGAACCCA GCCAGAATAACTGGCTACGAACTGATTGGATCACCCGAGAAGGGGCTCAGAGGGTGTATATTGAGATTAAATTCACCTTGAGGGACTGCA ATAGTCTTCCGGGCGTCATGGGGACTTGCAAGGAGACGTTTAACCTGTACTACTATGAATCAGACAACGACAAAGAGCGTTTCATCAGAG AGAACCAGTTTGTCAAAATTGACACCATTGCTGCTGATGAGAGCTTCACCCAAGTGGACATTGGTGACAGAATCATGAAGCTGAACACCG AGATCCGGGATGTAGGGCCATTAAGCAAAAAGGGGTTTTACCTGGCTTTTCAGGATGTGGGGGCCTGCATCGCCCTGGTATCAGTCCGTG TGTTCTATAAAAAGTGTCCACTCACAGTCCGCAATCTGGCCCAGTTTCCTGACACCATCACAGGGGCTGATACGTCTTCCCTGGTGGAAG TTCGAGGCTCCTGTGTCAACAACTCAGAAGAGAAAGATGTGCCAAAAATGTACTGTGGGGCAGATGGTGAATGGCTGGTACCCATTGGCA ACTGCCTATGCAACGCTGGGCATGAGGAGCGGAGCGGAGAATGCCAAGGGTTGTGTCTGTAAAGACAAAGGCCAGTGCTTCTGTGACGGG GCCAAAGGGGAGAAGGGGGAGAAGGGCTTTCCTGGACCCCCCGGTTCTCCTGGCCAGAAAGGATTCACAGGTCCTGAAGGCTTGCCTGGA CCGCAGGGACCCAAGGGCTTTCCAGGACTTCCAGGACTCACGGGTTCCAAAGGTGTAAGGGGAATAAGTGGATTGCCAGGATTTTCTGGT TCTCCTGGACTTCCAGGCACCCCAGGCAATACCGGGCCTTACGGACTTGTCGGTGTACCAGGATGCAGTGGTTCTAAGGGTGAGCAGGGG TTTCCAGGACTCCCAGGGACACTGGGCTACCCAGGGATCCCGGGTGCTGCTGGTTTGAAAGGACAAAAGGGTGCTCCTGCTAAAGAAGAA GATATAGAACTTGATGCAAAAGGCGACCCCGGGTTGCCAGGGGCTCCAGGACCCCAGGGTTTGCCAGGCCCTCCAGGTTTTCCTGGGCCT GTTGGCCCACCTGGTCCTCCGGGATTCTTTGGCTTTCCAGGAGCCATGGGACCTAGAGGACCTAAGGGTCACATGGGTGAAAGAGTGATA GGACATAAAGGAGAGCGGGGTGTGAAAGGGTTAACAGGACCCCCGGGACCACCAGGAACAGTTATTGTGACCCTAACTGGCCCAGATAAC AGAACGGACCTCAAGGGGGAAAAGGGAGACAAGGGAGCAATGGGCGAGCCTGGACCTCCTGGACCCTCAGGACTGCCTGGAGAATCATAT GGATCTGAAAAGGGTGCTCCTGGAGACCCTGGCCTGCAGGGAAAACCCGGAAAAGATGGTGTTCCTGGCTTCCCTGGAAGTGAGGGAGTC AAGGGCAACAGGGGTTTCCCTGGGTTAATGGGTGAAGATGGCATTAAGGGACAGAAAGGGGACATTGGCCCTCCAGGATTTCGTGGTCCA ACAGAATATTATGACACATACCAGGAAAAGGGAGATGAAGGCACTCCAGGCCCACCAGGGCCCAGAGGAGCTCGTGGCCCACAAGGTCCC AGTGGTCCCCCCGGAGTTCCTGGAAGTCCTGGATCATCAAGGCCTGGCCTCAGAGGAGCCCCTGGATGGCCAGGCCTGAAAGGAAGTAAA GGGGAACGAGGCCGCCCAGGAAAGGATGCCATGGGGACTCCTGGGTCCCCAGGTTGTGCTGGTTCACCAGGTCTTCCAGGATCACCGGGA CCTCCAGGACCGCCAGGTGACATCGTTTTTCGCAAGGGTCCACCTGGAGATCACGGACTGCCAGGCTATCTAGGGTCTCCAGGAATCCCA GGAGTTGATGGGCCCAAAGGAGAACCAGGCCTCCTGTGTACACAGTGCCCTTATATCCCAGGGCCTCCCGGTCTCCCAGGATTGCCAGGG TTACATGGTGTAAAAGGAATCCCAGGAAGACAAGGCGCAGCTGGCTTGAAAGGAAGCCCAGGGTCCCCAGGAAATACAGGTCTTCCAGGA TTTCCAGGTTTCCCAGGTGCCCAGGGTGACCCAGGACTTAAAGGAGAAAAAGGTGAAACACTTCAGCCTGAGGGGCAAGTGGGTGTCCCA GGTGACCCGGGGCTCAGAGGCCAACCTGGGAGAAAGGGCTTGGATGGAATTCCTGGAACTCCGGGAGTGAAAGGATTACCAGGACCTAAA GGCGAACTGGCTCTGAGTGGTGAGAAAGGGGACCAAGGTCCTCCAGGGGATCCTGGCTCCCCTGGGTCCCCAGGACCTGCAGGACCAGCT GGACCACCTGGCTACGGACCCCAAGGAGAACCTGGTCTCCAGGGCACGCAAGGAGTTCCTGGAGCCCCCGGACCACCCGGAGAAGCCGGC CCTAGGGGAGAGCTCAGTGTTTCAACACCAGTTCCAGGCCCACCAGGACCTCCAGGGCCCCCTGGCCATCCTGGCCCCCAAGGTCCACCT GGTATCCCTGGATCCCTGGGGAAATGTGGAGATCCTGGTCTTCCAGGGCCTGATGGTGAACCAGGAATTCCAGGAATTGGATTTCCTGGG CCTCCTGGACCTAAGGGAGACCAAGGTTTTCCAGGTACAAAAGGATCACTGGGTTGTCCTGGAAAAATGGGAGAGCCTGGGTTACCTGGA AAGCCAGGCCTCCCAGGAGCCAAGGGAGAACCAGCAGTAGCCATGCCTGGAGGACCAGGAACACCAGGTTTTCCAGGAGAAAGAGGCAAT TCTGGGGAACATGGAGAAATTGGACTCCCTGGACTTCCAGGTCTCCCTGGAACTCCAGGAAATGAAGGGCTTGATGGACCACGAGGAGAT CCAGGGCAGCCTGGACCACCTGGAGAACAAGGACCCCCAGGAAGGTGCATAGAGGGTCCCAGGGGAGCCCAAGGACTTCCAGGCTTAAAT GGATTGAAAGGGCAACAAGGCAGAAGAGGTAAAACGGGGCCAAAGGGAGACCCAGGAATTCCAGGCTTGGATAGATCAGGATTTCCTGGA GAAACTGGATCACCAGGAATTCCAGGTCATCAAGGTGAAATGGGACCACTGGGTCAAAGAGGATATCCAGGAAATCCGGGAATTTTAGGG CCACCAGGTGAAGATGGAGTGATTGGGATGATGGGCTTTCCTGGAGCCATTGGCCCTCCAGGGCCCCCTGGGAACCCAGGCACACCAGGG CAGAGGGGGAGCCCTGGAATTCCAGGAGTAAAGGGCCAGAGAGGAACCCCAGGAGCCAAGGGGGAACAAGGAGATAAAGGAAATCCCGGG CCTTCAGAGATATCCCACGTAATAGGGGACAAAGGAGAACCAGGTCTCAAAGGATTCGCAGGAAATCCAGGTGAGAAAGGAAACAGAGGC GTTCCAGGGATGCCAGGTTTAAAGGGCCTCAAAGGACTACCCGGACCAGCAGGACCACCAGGCCCCAGAGGAGATTTGGGCAGCACTGGG AATCCTGGAGAACCAGGACTGCGTGGTATACCAGGAAGCATGGGGAACATGGGCATGCCAGGTTCTAAAGGAAAAAGGGGAACTTTGGGA TTCCCAGGTCGAGCAGGAAGACCAGGCCTCCCAGGTATTCATGGTCTCCAGGGAGATAAGGGAGAGCCAGGTTATTCAGAAGGTACAAGG CCAGGACCACCGGGACCAACGGGGGATCCAGGACTGCCGGGTGATATGGGAAAGAAAGGAGAAATGGGGCAACCTGGCCCACCTGGACAT TTGGGGCCTGCTGGACCTGAGGGAGCCCCTGGAAGTCCTGGAAGTCCTGGCCTCCCAGGAAAGCCAGGTCCTCATGGTGATTTGGGTTTT AAAGGAATCAAAGGCCTCCTGGGCCCTCCAGGAATCAGAGGCCCTCCAGGTCTTCCAGGATTTCCAGGATCTCCTGGACCAATGGGTATA AGAGGTGACCAAGGACGTGATGGAATTCCTGGTCCAGCCGGAGAAAAGGGAGAAACGGGTTTATTGAGGGCCCCTCCAGGCCCAAGAGGG AACCCTGGTGCTCAAGGAGCCAAAGGAGACAGGGGAGCCCCAGGTTTTCCTGGCCTCCCGGGCAGAAAAGGGGCCATGGGAGATGCTGGA CCTCGAGGACCCACAGGCATAGAAGGATTCCCAGGGCCACCAGGTCTGCCCGGTGCAATTATCCCTGGCCAGACAGGAAATCGTGGTCCA CCAGGCTCAAGAGGAAGCCCAGGTGCGCCTGGTCCCCCTGGACCTCCAGGGAGTCATGTAATAGGCATAAAAGGAGACAAAGGGTCTATG GGCCACCCTGGCCCAAAAGGTCCACCTGGAACTGCAGGAGACATGGGACCACCAGGTCGTCTGGGAGCACCAGGTACTCCAGGTCTTCCA GGACCCAGAGGTGATCCTGGATTCCAGGGGTTTCCAGGCGTGAAAGGAGAAAAGGGTAATCCTGGATTTCTAGGATCCATTGGACCTCCA GGACCAATTGGGCCAAAAGGACCACCTGGTGTACGTGGAGACCCTGGCACACTTAAGATTATCTCCCTTCCAGGAAGCCCAGGGCCACCT GGCACACCTGGAGAACCAGGGATGCAGGGAGAACCTGGGCCACCAGGGCCACCTGGAAACCTAGGACCCTGTGGGCCAAGAGGTAAGCCA GGCAAGGATGGAAAACCAGGAACTCCTGGACCAGCTGGAGAAAAAGGCAACAAAGGTTCTAAAGGAGAGCCAGGACCAGCTGGATCAGAT GGATTGCCAGGTTTGAAAGGAAAACGTGGAGACAGTGGATCACCTGCAACCTGGACAACGAGAGGCTTTGTCTTCACCCGACACAGTCAA ACCACAGCAATTCCTTCATGTCCAGAGGGGACAGTGCCACTCTACAGTGGGTTTTCTTTTCTTTTTGTACAAGGAAATCAACGAGCCCAC GGACAAGACCTTGGAACTCTTGGCAGCTGCCTGCAGCGATTTACCACAATGCCATTCTTATTCTGCAATGTCAATGATGTATGTAATTTT GCATCTCGAAATGATTATTCATACTGGCTGTCAACACCAGCTCTGATGCCAATGAACATGGCTCCCATTACTGGCAGAGCCCTTGAGCCT TATATAAGCAGATGCACTGTTTGTGAAGGTCCTGCGATCGCCATAGCCGTTCACAGCCAAACCACTGACATTCCTCCATGTCCTCACGGC TGGATTTCTCTCTGGAAAGGATTTTCATTCATCATGTTCACAAGTGCAGGTTCTGAGGGCACCGGGCAAGCACTGGCCTCCCCTGGCTCC TGCCTGGAAGAATTCCGAGCCAGCCCATTTCTAGAATGTCATGGAAGAGGAACGTGCAACTACTATTCAAATTCCTACAGTTTCTGGCTG GCTTCATTAAACCCAGAAAGAATGTTCAGAAAGCCTATTCCATCAACTGTGAAAGCTGGGGAATTAGAAAAAATAATAAGTCGCTGTCAG GTGTGCATGAAGAAAAGACACTGAAGCTAAAAAAGACAGCAGAACTGCTATTTTTCATCCTAAAGAACAAAGTAATGACAGAACATGCTG TTATTTAGGTATTTTTCTTTAACCAAACAATATTGCTCCATGATGACTTAGTACAAAGTTTCAATTTGTTTCCCCACAAAACAAAGCAAT TCTTTCAAGTCAGTTCTGTGATCTGGGTCTCTAATCTGTGCTGTTTCAAAGTTCTCTGTGGCAAAGCAGCAACTATTCACAAAATATCAC CAAAAACCTATTCCACTTACATCCAAGGCACTGTCACTACGGTGATTGTATGAAGTTTGAATGCTGCAAGTTATGAAATATTTGGCCCGC TGGATTCCCACATTTGTCTTCTTTCTGTCTTTAAGACTCAGGGAGGCTAAATCAGTGTTTGATTGCCCCGCCAACCCTTCCTGAAACTTC AGACCCTGGGTAGGGGAAGAGAAGGGGGCATGTGGTATCCTGGAGCATTGTGTATAGAACTGGATTTTCAGACCTGCTGAGGACCGTAAG GCCTGATGGAACACAGAACTGAACTGAGGTTCATGGATTTTCCAGGACTGTTTCAAACATGCCCATTACTAACGGCAAAAGGGGGATTCC CTGATGGAACCATAATACCCTTGGAAATACTGTATGGTTTTGTTTTGTTTTGTTGGTTTTTAAAGATTTTTGTTTGTTTATTGAATTCAT TTCACTGTAGCTCTAAAATCTGCTTGTATTCCAAGCATATAAAATTTTCCCCCTTAGTGAATTAGTTTTAAAATGATATTGTTATATACA TACTATGAAATATGTATAACTTTAACTTCTGTTTTACCAGCATACCCACACAAATAACAAGAATACTACTTATGAAATGTGCACTTTATC CTCATTCCATAAATGTCGGTGCATACCTTATGTAAGGGAGCAGTTCAATAATCCATGAAAGAACTTAAGGCATTTGTTGGTTTATCAGAC TCGGAATCTATTTTCTCATTGCTCTGAATATGTCATCACTCTAGGTTTTACAGATTTATTCCTTTGTTACTTCTCTAATTCTTCCTTTGT AAAAAAAAAAAAAAGCAACACTTTTTATGTTATATGTTGTTCTTACAAACCATACTGAAAGAGTCCATTGTTTAAAAATCTTAATGTATC AAACTGTATAACTTGGCCGCTGTATGTCTTAAAACCTGCTTTTCAATGTGTTGATACATTCCCAAGGTTACTTAATTCAACTTAACTATC ATCTTATTCAGCACCAAGCATGTCCCAGGCACTGTACTAACCTACAGAGATGCTAAGAGAAAAAAAAGACTTGTTTCTGATCTAATATCC CAGAAAAAGTAACTCATTGCTCTGTTAATAATCTCACATATACAAGTAGCTTCCCTCCCCTCTAGTTTTTTCTTCCTTTTCACTGCTGTT ATATTTCATCATGATAATTCAGCAGGCCCAAGTAAAGGTTAAAAATAAGGTCTATGCCTAGGGAAACTCAGGGCTTCTAGTTTCTCTTAG AAAAGCTAAGAGAAGATAAGGTCTGAATAATAGCAGAAAAACCAACATCTACAAAACATTAAACTAGTGTTATACTTGATGATAACACTA TTTGATGAGTCTTAGAGTCCAGACACAAAGAGACAAAGCTTTGAAGATGCTTTTTGATCTACCTAGGTGGAGTTGGTGGTGCTGATATTT AAATTCAGGCTACTGCTTCAATCTCAATTGCTTTGTAAGTGAAAAACATGACCCAGAGGACAGCACAGACTATGGCCATGGCTCACATGG TTTACATCCTTCACTGCTCACGTGTTTGCTGTCAAGCCATTTTTACATCTAAACTAAGATGTGCAGCATTTCACTTATTTAGATTCACTT AACAAACAAATTTTTCTGCTTTAAAAATGTCTTATTGTCCCAAGTGTACTATAGCGGCATATAGAGCTAGCTAATCTCTACAAACCCTCT GTAGGCCAGTAGTTCTCAAAGTGTGGTCTCTGGAAGAGCAGTATCAGCATCATCTGGGAACTTGTCACAGATGCAGATTCTAGGGACCAC TCCAGACCTACACAATCAGAAACTCTTGGGGGAGGGCCCGAAATATCTATGTTTTACCAAGCCCACCACATGATTCTGATGTACTCTAAA TACTGAGAAAACCTGTTCTAGACAAATACCCAAGCAACAACTCCGCAGGCAGTTACCAAGTACGGCTGGCTACAACTGCTCCATCCGTGC CTCTTTTTAAAGTTCAAACTCACAGGTGACTCTAAGGTTATCTACTTTTACTCATAAGTAAAAGCCCTAGACTGGTGCTAATGTCAAACC ACTGGCCTCCACTCAGGCCTCCATCTTCTCATGCCCTCTTACCAGTATTTAACTTCTGAGGAAGACAAGTGATGCTAAAACCTGAAATTC CAATGAAGCCATATGAACAGCTGTTCAGTTGCACTTCTAAGACTTTACTTAGCAGTAAATTATAGCTCATGTGCATTATTTTCCAGATAA CTTAGCTTATGAGTAGCTTATACAATTATGAAGATTTAATATTACAGATAAAATGTAAACTGTTTCTTTAAAATTGGGGCTTCAACTTTG GAATTTCACAGCGTGCTAAAATAACAGATTTCTCAGAAGTCTTTCAGCAAGATAAACATTATTAAGTAACTTATTTATGAAAGTATTAAA ATGCTTACATTTGAACTTGATGGCTAACTTACAAAGATTCTCTATGTATCAAATGTAACTTACTGCGACTAAACTTAATTTAATATTTAC TCTATAACCAAATGAAATATATTTAAAATATATTGAATATTTTATATTGTTATATCCTGACAAGATTATAATATTTTAATGTACTAATAT >26960_26960_2_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000409854_COL4A3_chr2_228102684_ENST00000396578_length(amino acids)=1729AA_BP=1161 MWGPASPWYQSVCSIKSVHSQSAIWPSFLTPSQGLIRLPWWKFEAPVSTTQKRKMCQKCTVGQMVNGWYPLATAYATLGMRSGAENAKGC VCKDKGQCFCDGAKGEKGEKGFPGPPGSPGQKGFTGPEGLPGPQGPKGFPGLPGLTGSKGVRGISGLPGFSGSPGLPGTPGNTGPYGLVG VPGCSGSKGEQGFPGLPGTLGYPGIPGAAGLKGQKGAPAKEEDIELDAKGDPGLPGAPGPQGLPGPPGFPGPVGPPGPPGFFGFPGAMGP RGPKGHMGERVIGHKGERGVKGLTGPPGPPGTVIVTLTGPDNRTDLKGEKGDKGAMGEPGPPGPSGLPGESYGSEKGAPGDPGLQGKPGK DGVPGFPGSEGVKGNRGFPGLMGEDGIKGQKGDIGPPGFRGPTEYYDTYQEKGDEGTPGPPGPRGARGPQGPSGPPGVPGSPGSSRPGLR GAPGWPGLKGSKGERGRPGKDAMGTPGSPGCAGSPGLPGSPGPPGPPGDIVFRKGPPGDHGLPGYLGSPGIPGVDGPKGEPGLLCTQCPY IPGPPGLPGLPGLHGVKGIPGRQGAAGLKGSPGSPGNTGLPGFPGFPGAQGDPGLKGEKGETLQPEGQVGVPGDPGLRGQPGRKGLDGIP GTPGVKGLPGPKGELALSGEKGDQGPPGDPGSPGSPGPAGPAGPPGYGPQGEPGLQGTQGVPGAPGPPGEAGPRGELSVSTPVPGPPGPP GPPGHPGPQGPPGIPGSLGKCGDPGLPGPDGEPGIPGIGFPGPPGPKGDQGFPGTKGSLGCPGKMGEPGLPGKPGLPGAKGEPAVAMPGG PGTPGFPGERGNSGEHGEIGLPGLPGLPGTPGNEGLDGPRGDPGQPGPPGEQGPPGRCIEGPRGAQGLPGLNGLKGQQGRRGKTGPKGDP GIPGLDRSGFPGETGSPGIPGHQGEMGPLGQRGYPGNPGILGPPGEDGVIGMMGFPGAIGPPGPPGNPGTPGQRGSPGIPGVKGQRGTPG AKGEQGDKGNPGPSEISHVIGDKGEPGLKGFAGNPGEKGNRGVPGMPGLKGLKGLPGPAGPPGPRGDLGSTGNPGEPGLRGIPGSMGNMG MPGSKGKRGTLGFPGRAGRPGLPGIHGLQGDKGEPGYSEGTRPGPPGPTGDPGLPGDMGKKGEMGQPGPPGHLGPAGPEGAPGSPGSPGL PGKPGPHGDLGFKGIKGLLGPPGIRGPPGLPGFPGSPGPMGIRGDQGRDGIPGPAGEKGETGLLRAPPGPRGNPGAQGAKGDRGAPGFPG LPGRKGAMGDAGPRGPTGIEGFPGPPGLPGAIIPGQTGNRGPPGSRGSPGAPGPPGPPGSHVIGIKGDKGSMGHPGPKGPPGTAGDMGPP GRLGAPGTPGLPGPRGDPGFQGFPGVKGEKGNPGFLGSIGPPGPIGPKGPPGVRGDPGTLKIISLPGSPGPPGTPGEPGMQGEPGPPGPP GNLGPCGPRGKPGKDGKPGTPGPAGEKGNKGSKGEPGPAGSDGLPGLKGKRGDSGSPATWTTRGFVFTRHSQTTAIPSCPEGTVPLYSGF SFLFVQGNQRAHGQDLGTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVH SQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EPHA4-COL4A3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EPHA4-COL4A3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EPHA4-COL4A3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EPHA4 | C0002736 | Amyotrophic Lateral Sclerosis | 1 | ORPHANET |
Tgene | C4746547 | ALPORT SYNDROME 3, AUTOSOMAL DOMINANT | 5 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C4746745 | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 5 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0241908 | Hematuria, Benign Familial | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1567741 | Alport Syndrome | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1567742 | Alport Syndrome, X-Linked | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1567743 | Alport Syndrome, Autosomal Dominant | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1567744 | Alport Syndrome, Autosomal Recessive | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0027706 | Hereditary nephritis | 1 | CTD_human | |
Tgene | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | ORPHANET | |
Tgene | C2931861 | Hemorrhagic hereditary nephritis | 1 | CTD_human |